BeOne Medicines Ltd. — Director's Dealing 2023

Jan 12, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2023-01-10

Reporting Person: OYLER JOHN (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-10	American Depositary Shares	S	879	$246.9951	Disposed	5918	Direct
2023-01-10	American Depositary Shares	S	2442	$247.7357	Disposed	3476	Direct
2023-01-10	American Depositary Shares	S	1336	$248.7626	Disposed	2140	Direct
2023-01-10	American Depositary Shares	S	1948	$249.8361	Disposed	192	Direct
2023-01-10	American Depositary Shares	S	192	$250.2613	Disposed	0	Direct
2023-01-10	American Depositary Shares	S	879	$246.9958	Disposed	5918	Indirect
2023-01-10	American Depositary Shares	S	2442	$247.7358	Disposed	3476	Indirect
2023-01-10	American Depositary Shares	S	1336	$248.7628	Disposed	2140	Indirect
2023-01-10	American Depositary Shares	S	1948	$249.8363	Disposed	192	Indirect
2023-01-10	American Depositary Shares	S	192	$250.2613	Disposed	0	Indirect
2023-01-10	American Depositary Shares	S	879	$246.9661	Disposed	5918	Indirect
2023-01-10	American Depositary Shares	S	2442	$247.7359	Disposed	3476	Indirect
2023-01-10	American Depositary Shares	S	1336	$248.7631	Disposed	2140	Indirect
2023-01-10	American Depositary Shares	S	1947	$249.8363	Disposed	193	Indirect
2023-01-10	American Depositary Shares	S	193	$250.2612	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	1615913	Direct
Ordinary Shares	481533	Indirect
Ordinary Shares	7727927	Indirect
Ordinary Shares	28984115	Indirect
Ordinary Shares	9545000	Indirect
Ordinary Shares	102188	Indirect

Footnotes

F1: These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.

F2: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

F3: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

F4: These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.

F5: These securities are held by The John Oyler Legacy Trust, of which the Reporting Person's father is a trustee, for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

F6: Each American Depositary Share represents 13 Ordinary Shares.

F7: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.21 to $247.20, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.21 to $248.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.23 to $249.22, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.23 to $250.19, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.26 to $250.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F13: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2022.